290 related articles for article (PubMed ID: 12111306)
21. Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis.
Moreira MA; Tilbery CP; Monteiro LP; Teixeira MM; Teixeira AL
Acta Neurol Scand; 2006 Aug; 114(2):109-13. PubMed ID: 16867033
[TBL] [Abstract][Full Text] [Related]
22. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients.
Sørensen TL; Tani M; Jensen J; Pierce V; Lucchinetti C; Folcik VA; Qin S; Rottman J; Sellebjerg F; Strieter RM; Frederiksen JL; Ransohoff RM
J Clin Invest; 1999 Mar; 103(6):807-15. PubMed ID: 10079101
[TBL] [Abstract][Full Text] [Related]
23. Abnormal expression of chemokine receptors in Behçet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.
Houman H; Hamzaoui A; Ben Ghorbal I; Khanfir M; Feki M; Hamzaoui K
J Autoimmun; 2004 Nov; 23(3):267-73. PubMed ID: 15501397
[TBL] [Abstract][Full Text] [Related]
24. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
[TBL] [Abstract][Full Text] [Related]
25. Increased CXCL8 (IL-8) expression in Multiple Sclerosis.
Lund BT; Ashikian N; Ta HQ; Chakryan Y; Manoukian K; Groshen S; Gilmore W; Cheema GS; Stohl W; Burnett ME; Ko D; Kachuck NJ; Weiner LP
J Neuroimmunol; 2004 Oct; 155(1-2):161-71. PubMed ID: 15342208
[TBL] [Abstract][Full Text] [Related]
26. Expression of chemokine receptors in the different clinical forms of multiple sclerosis.
Martínez-Cáceres EM; Espejo C; Brieva L; Pericot I; Tintoré M; Sáez-Torres I; Montalban X
Mult Scler; 2002 Oct; 8(5):390-5. PubMed ID: 12356205
[TBL] [Abstract][Full Text] [Related]
27. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
Zeremski M; Petrovic LM; Talal AH
J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
[TBL] [Abstract][Full Text] [Related]
28. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis.
Wedderburn LR; Robinson N; Patel A; Varsani H; Woo P
Arthritis Rheum; 2000 Apr; 43(4):765-74. PubMed ID: 10765921
[TBL] [Abstract][Full Text] [Related]
29. CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha.
Narikawa K; Fujihara K; Misu T; Feng J; Fujimori J; Nakashima I; Miyazawa I; Saito H; Sato S; Itoyama Y
J Neuroimmunol; 2005 Feb; 159(1-2):177-82. PubMed ID: 15652417
[TBL] [Abstract][Full Text] [Related]
30. Memory and naïve B-cell subsets in patients with multiple sclerosis.
Niino M; Hirotani M; Miyazaki Y; Sasaki H
Neurosci Lett; 2009 Oct; 464(1):74-8. PubMed ID: 19666086
[TBL] [Abstract][Full Text] [Related]
31. Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.
Fox RJ; Kivisakk P; Fisher E; Tucky B; Lee JC; Rudick RA; Ransohoff RM
Mult Scler; 2008 Sep; 14(8):1036-43. PubMed ID: 18701575
[TBL] [Abstract][Full Text] [Related]
32. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS.
Giunti D; Borsellino G; Benelli R; Marchese M; Capello E; Valle MT; Pedemonte E; Noonan D; Albini A; Bernardi G; Mancardi GL; Battistini L; Uccelli A
J Leukoc Biol; 2003 May; 73(5):584-90. PubMed ID: 12714572
[TBL] [Abstract][Full Text] [Related]
34. Association of Th1/Th2-related chemokine receptors in peripheral T cells with disease activity in patients with multiple sclerosis and neuromyelitis optica.
Shimizu Y; Ota K; Kubo S; Kabasawa C; Kobayashi M; Ohashi T; Uchiyama S
Eur Neurol; 2011; 66(2):91-7. PubMed ID: 21846991
[TBL] [Abstract][Full Text] [Related]
35. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis.
Facco M; Baesso I; Miorin M; Bortoli M; Cabrelle A; Boscaro E; Gurrieri C; Trentin L; Zambello R; Calabrese F; Cassatella MA; Semenzato G; Agostini C
J Leukoc Biol; 2007 Oct; 82(4):946-55. PubMed ID: 17615381
[TBL] [Abstract][Full Text] [Related]
36. Chemokine receptor CCR5 in interferon-treated multiple sclerosis.
Sellebjerg F; Kristiansen TB; Wittenhagen P; Garred P; Eugen-Olsen J; Frederiksen JL; Sørensen TL
Acta Neurol Scand; 2007 Jun; 115(6):413-8. PubMed ID: 17511851
[TBL] [Abstract][Full Text] [Related]
37. CCL5, CXCL10 and CXCL11 chemokines in patients with active and stable relapsing-remitting multiple sclerosis.
Szczuciński A; Losy J
Neuroimmunomodulation; 2011; 18(1):67-72. PubMed ID: 20720435
[TBL] [Abstract][Full Text] [Related]
38. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis.
Jilek S; Schluep M; Rossetti AO; Guignard L; Le Goff G; Pantaleo G; Du Pasquier RA
Clin Immunol; 2007 Apr; 123(1):105-13. PubMed ID: 17188575
[TBL] [Abstract][Full Text] [Related]
39. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS.
Sellebjerg F; Börnsen L; Khademi M; Krakauer M; Olsson T; Frederiksen JL; Sørensen PS
Neurology; 2009 Dec; 73(23):2003-10. PubMed ID: 19996075
[TBL] [Abstract][Full Text] [Related]
40. Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis.
Julià E; Montalban X; Al-Zayat H; Issazadeh-Navikas S; Goertsches R; Martin R; Comabella M
J Neuroimmunol; 2006 Nov; 180(1-2):147-58. PubMed ID: 16899302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
